Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2024;14(1): 67-85. doi: 10.34172/apb.2024.018
PMID: 38585458        PMCID: PMC10997930

Review Article

Transdermal Drug Delivery Systems: A Focused Review of the Physical Methods of Permeation Enhancement

Rifath Sheikh Vaseem 1 ORCID, Alison D’cruz 1, Srishti Shetty 1, Hafsa - 1, Aditya Vardhan 1, Shreya Shenoy R 1, Shirleen Miriam Marques 1, Lalit Kumar 1,2 * ORCID, Ruchi Verma 3

Cited by CrossRef: 0

1- Upadhyay A, Tripathi S, Malviya A, Kohli K, Mishra S. Transdermal Therapeutics for Psoriasis Management Using Minimally Invasive Approaches. J Pharm Innov. 2025;20(6) [Crossref]
2- Elnaggar M, Mekkawy A, Taha A, Abdel-maksoud F, Elnaggar M, Tawfeek H, Tamam H. Mizolastine-loaded Spanlastics for treatment of Atopic Dermatitis: Immunomodulatory approach for management of inflammation. Journal of Drug Targeting. 2025;:1 [Crossref]
3- Ghumare G, Salve P, Hussain U, Tatode A, Qutub M, Premchandani T, Tammewar S. Nanotechnology-Driven Transdermal System for Loxapine Succinate: A Novel Strategy To Improve Pharmacokinetics and Therapeutics in Psychotic Disorders. J Pharm Innov. 2025;20(5) [Crossref]
4- Seenivasan R, Halagali P, Nayak D, Tippavajhala V. Transethosomes: A Comprehensive Review of Ultra-Deformable Vesicular Systems for Enhanced Transdermal Drug Delivery. AAPS PharmSciTech. 2025;26(1) [Crossref]
5- Brock G, Hellstrom W, Giraldi A, Honig S. Addressing unmet needs for patients with erectile dysfunction: a narrative review of topical therapies. 2025;13(2) [Crossref]
6- Addissouky T. Advancing frontiers in skin offensive odor management: from innovative diagnostics to cutting-edge treatments and emerging technologies. Arch Dermatol Res. 2025;317(1) [Crossref]
7- Momin Z, D. M, B. P, K. V, Kumar L. Formulation, characterization, and evaluation of transdermal patches of ranolazine for chronic angina pectoris. Naunyn-Schmiedeberg's Arch Pharmacol. 2025; [Crossref]
8- Rahamathulla M, Devanshi S, Saisivam S, Kalaria V, Chakraborty S, Hani U, Ahmed M, Thajudeen K. Formulation and Characterization of Nadolol Transdermal Delivery Using 3² Factorial Design: In Vitro and Ex Vivo Evaluation. J Pharm Innov. 2026;21(1) [Crossref]
9- Sultana N, Al Kausor M. Eutectic formulations in pharmaceutical development: a comprehensive review of modulation strategies. RSC Pharm. 2025;2(6):1408 [Crossref]
10- Panda P, Mohanty T, Mohapatra R. Advancements in Transdermal Drug Delivery Systems: Harnessing the Potential of Macromolecular Assisted Permeation Enhancement and Novel Techniques. AAPS PharmSciTech. 2025;26(1) [Crossref]
11- Yakimov K, Nogaeva U, Flisyuk E. Development and pharmacotechnological studies of transdermal patches with trans-resveratrol. Razrabotka i registraciâ lekarstvennyh sredstv. 2025; [Crossref]
12- Arguello A, Sadhnani G, Leung J, Moawad F, Cullis P, Hedtrich S, Brambilla D. Spatially Defined Post-manufacturing Loading of Nanoparticles into Hydrogel-Forming Microneedles. Mol Pharmaceutics. 2025;22(8):4778 [Crossref]
13- Gopal K, Mahmood S, Sofian Z, Hilles A, Hashim N. Microneedle Innovations in Oral Therapeutics: Transforming Protein and Peptide Delivery. AAPS PharmSciTech. 2025;26(5) [Crossref]
14- Bajwa N, Devulapalli V, Devulapalli M, Gopi K, Shariff S, Kumar P, Quispe-Vicuña C. Microneedle technology: a gateway to transformative healthcare solutions. theevi. 2024;2(3) [Crossref]
15- Kalambhe D, Shelke O, Deshpande A, Huang Y. In-vitro Efficacy and In-vivo Safety Study of a Transdermal Formulation Containing ‎Flavonoid-Rich Extract from Curcuma Longa L.. J Pharm Innov. 2026;21(1) [Crossref]